Detalles de la búsqueda
1.
Dual targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: A phase 2 trial.
Cancer Sci;
114(3): 1067-1074, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36382603
2.
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
BMC Cancer;
23(1): 676, 2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464378
3.
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.
BMC Med;
20(1): 155, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513832
4.
Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.
Int J Med Sci;
18(4): 911-920, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33456348
5.
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Int J Cancer;
146(7): 2027-2035, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31693169
6.
CSCO guidelines for colorectal cancer version 2023: Updates and insights.
Chin J Cancer Res;
35(3): 233-238, 2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37440826
7.
SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
Cell Physiol Biochem;
44(4): 1485-1496, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29190626
8.
CSCO guidelines for colorectal cancer version 2022: Updates and discussions.
Chin J Cancer Res;
34(2): 67-70, 2022 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685997
9.
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020.
Chin J Cancer Res;
33(3): 302-307, 2021 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34321827
10.
How should we correctly interpret biallelic germline truncating variant of MLH3 in hereditary colorectal cancer?
Genet Med;
21(11): 2650-2651, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31043711
11.
Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: a comprehensive integrated analysis.
Front Mol Biosci;
10: 1162409, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503539
12.
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial.
EClinicalMedicine;
62: 102123, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554125
13.
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol.
Technol Cancer Res Treat;
22: 15330338231152350, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727222
14.
The impact of the COVID-19 pandemic on the mental health and academic performance of medical postgraduates.
Front Public Health;
10: 948710, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36187668
15.
[Effects of osteopontin on gap junctional intercellular communication in colon cancer cell lines].
Zhonghua Yi Xue Za Zhi;
91(36): 2578-81, 2011 Sep 27.
Artículo
en Zh
| MEDLINE | ID: mdl-22321891
16.
Primary tumor location (right versus left side of the colon) and resection affect the survival of patients with liver metastases from colonic neuroendocrine carcinoma: a population-based study.
Therap Adv Gastroenterol;
14: 17562848211036453, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34733354
17.
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.
World J Gastroenterol;
27(47): 8123-8137, 2021 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35068858
18.
Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns.
Cancer Med;
10(1): 135-142, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125191
19.
SPARCL1 exhibits different expressions in left- and right-sided colon cancer and is downregulated via DNA methylation.
Epigenomics;
13(16): 1269-1282, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34435512
20.
[K-ras gene mutation in colorectal cancer and its clinicopathologic significance].
Zhonghua Wai Ke Za Zhi;
48(16): 1247-51, 2010 Aug 15.
Artículo
en Zh
| MEDLINE | ID: mdl-21055216